Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism PKR agonists(eukaryotic translation initiation factor 2 alpha kinase 2 agonists), USP9X agonists(ubiquitin specific peptidase 9 X-linked agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemic and Lymphatic Diseases | Discovery | - | 29 Jun 2023 | |
Neoplasms | Discovery | - | 29 Jun 2023 | |
Other Diseases | Discovery | - | 29 Jun 2023 |